Acute Invasive Aspergillosis Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Type (Antifungal, and Corticosteroids); Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and Geography

Report Code: TIPRE00023423 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Acute Invasive Aspergillosis is an acute infection or fungal growth that rises due to Aspergillus fungus. In general, everyone comes in contact with the Aspergillus fungus as it is present on decaying vegetation and dead leaves; however, not everyone is at risk of the infection. Aspergillosis is categorized into specific types like invasive aspergillosis, chronic pulmonary aspergillosis, allergic bronchopulmonary aspergillosis, allergic aspergillus sinusitis, aspergilloma, and cutaneous aspergillosis. Active invasive aspergillosis is a rare, opportunistic, and fungal severe infection, which affects immunocompromised patients or those suffering from lung diseases. Risk factors responsible for developing invasive aspergillosis infection include the weakened immune system, low white blood cell count, presence of lung cavities, asthma or cystic fibrosis, and long-term corticosteroid therapy. Commercially available drugs for treating aspergillus infection include Voriconazole, Caspofungin, and Amphotericin B, among others.

MARKET SCOPE

The "Global Acute Invasive Aspergillosis Treatment Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Acute invasive aspergillosis treatment market with detailed market segmentation by type, end use, and geography. The report provides key statistics on the market status of the leading Acute invasive aspergillosis treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on drug type, the global Acute invasive aspergillosis treatment market is segmented into antifungal and corticosteroid. Antifungal is again segmented into voriconazole, capsofungin, itraconazole, isavuconazole, amphotericin b, and others, and corticosteroids is segmented into prednisolone, prednisone, and methylprednisolone.
  •  On the basis of distribution channel, the market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies.

MARKET DYNAMICS
Drivers

  •  Rise in the numbers of solid organ transplants.
  •  Rise in the approval of drugs for the treatment of this infection.
  •  Increase in prevalence of aspergillosis around the world.

Restraints

  •  The drug resistance to antifungal medications is the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Acute invasive aspergillosis treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Acute invasive aspergillosis treatment market in these regions.

IMPACT OF COVID-19 ON ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Acute invasive aspergillosis treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Acute invasive aspergillosis treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Acute invasive aspergillosis treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Acute invasive aspergillosis treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  GlaxoSmithKline
  •  Mylan Pharmaceuticals, Inc.
  •  Novartis AG
  •  Abbott Laboratories
  •  Eli Lilly and Company
  •  AstraZeneca Plc
  •  Pfizer, Inc.
  •  Johnson & Johnson
  •  Takeda Pharmaceutical Company Ltd.
  •  Astellas

The Insight Partner's dediAcute invasive aspergillosis treatmented research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Acute Invasive Aspergillosis Treatment Market - By Drug Type
1.3.2 Acute Invasive Aspergillosis Treatment Market - By Distribution Channel
1.3.3 Acute Invasive Aspergillosis Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. ACUTE INVASIVE ASPERGILLOSIS TREATMENT - GLOBAL MARKET OVERVIEW
6.2. ACUTE INVASIVE ASPERGILLOSIS TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTIFUNGAL
7.3.1. Overview
7.3.2. Antifungal Market Forecast and Analysis
7.3.3. Voriconazole Market
7.3.3.1. Overview
7.3.3.2. Voriconazole Market Forecast and Analysis
7.3.4. Capsofungin Market
7.3.4.1. Overview
7.3.4.2. Capsofungin Market Forecast and Analysis
7.3.5. Itraconazole Market
7.3.5.1. Overview
7.3.5.2. Itraconazole Market Forecast and Analysis
7.3.6. Isavuconazole Market
7.3.6.1. Overview
7.3.6.2. Isavuconazole Market Forecast and Analysis
7.3.7. Amphotericin B Market
7.3.7.1. Overview
7.3.7.2. Amphotericin B Market Forecast and Analysis
7.3.8. Others Market
7.3.8.1. Overview
7.3.8.2. Others Market Forecast and Analysis
7.4. CORTICOSTEROIDS
7.4.1. Overview
7.4.2. Corticosteroids Market Forecast and Analysis
7.4.3. Prednisolone Market
7.4.3.1. Overview
7.4.3.2. Prednisolone Market Forecast and Analysis
7.4.4. Prednisone Market
7.4.4.1. Overview
7.4.4.2. Prednisone Market Forecast and Analysis
7.4.5. Methylprednisolone Market
7.4.5.1. Overview
7.4.5.2. Methylprednisolone Market Forecast and Analysis
8. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. ONLINE PHARMACIES
8.4.1. Overview
8.4.2. Online Pharmacies Market Forecast and Analysis
8.5. RETAIL PHARMACIES
8.5.1. Overview
8.5.2. Retail Pharmacies Market Forecast and Analysis
9. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Acute Invasive Aspergillosis Treatment Market Overview
9.1.2 North America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis
9.1.3 North America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Drug Type
9.1.4 North America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Acute Invasive Aspergillosis Treatment Market
9.1.5.1.1 United States Acute Invasive Aspergillosis Treatment Market by Drug Type
9.1.5.1.2 United States Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.1.5.2 Canada Acute Invasive Aspergillosis Treatment Market
9.1.5.2.1 Canada Acute Invasive Aspergillosis Treatment Market by Drug Type
9.1.5.2.2 Canada Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.1.5.3 Mexico Acute Invasive Aspergillosis Treatment Market
9.1.5.3.1 Mexico Acute Invasive Aspergillosis Treatment Market by Drug Type
9.1.5.3.2 Mexico Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Acute Invasive Aspergillosis Treatment Market Overview
9.2.2 Europe Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis
9.2.3 Europe Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Acute Invasive Aspergillosis Treatment Market
9.2.5.1.1 Germany Acute Invasive Aspergillosis Treatment Market by Drug Type
9.2.5.1.2 Germany Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.2.5.2 France Acute Invasive Aspergillosis Treatment Market
9.2.5.2.1 France Acute Invasive Aspergillosis Treatment Market by Drug Type
9.2.5.2.2 France Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.2.5.3 Italy Acute Invasive Aspergillosis Treatment Market
9.2.5.3.1 Italy Acute Invasive Aspergillosis Treatment Market by Drug Type
9.2.5.3.2 Italy Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.2.5.4 Spain Acute Invasive Aspergillosis Treatment Market
9.2.5.4.1 Spain Acute Invasive Aspergillosis Treatment Market by Drug Type
9.2.5.4.2 Spain Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.2.5.5 United Kingdom Acute Invasive Aspergillosis Treatment Market
9.2.5.5.1 United Kingdom Acute Invasive Aspergillosis Treatment Market by Drug Type
9.2.5.5.2 United Kingdom Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.2.5.6 Rest of Europe Acute Invasive Aspergillosis Treatment Market
9.2.5.6.1 Rest of Europe Acute Invasive Aspergillosis Treatment Market by Drug Type
9.2.5.6.2 Rest of Europe Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Acute Invasive Aspergillosis Treatment Market Overview
9.3.2 Asia-Pacific Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Acute Invasive Aspergillosis Treatment Market
9.3.5.1.1 Australia Acute Invasive Aspergillosis Treatment Market by Drug Type
9.3.5.1.2 Australia Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.3.5.2 China Acute Invasive Aspergillosis Treatment Market
9.3.5.2.1 China Acute Invasive Aspergillosis Treatment Market by Drug Type
9.3.5.2.2 China Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.3.5.3 India Acute Invasive Aspergillosis Treatment Market
9.3.5.3.1 India Acute Invasive Aspergillosis Treatment Market by Drug Type
9.3.5.3.2 India Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.3.5.4 Japan Acute Invasive Aspergillosis Treatment Market
9.3.5.4.1 Japan Acute Invasive Aspergillosis Treatment Market by Drug Type
9.3.5.4.2 Japan Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.3.5.5 South Korea Acute Invasive Aspergillosis Treatment Market
9.3.5.5.1 South Korea Acute Invasive Aspergillosis Treatment Market by Drug Type
9.3.5.5.2 South Korea Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.3.5.6 Rest of Asia-Pacific Acute Invasive Aspergillosis Treatment Market
9.3.5.6.1 Rest of Asia-Pacific Acute Invasive Aspergillosis Treatment Market by Drug Type
9.3.5.6.2 Rest of Asia-Pacific Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Acute Invasive Aspergillosis Treatment Market Overview
9.4.2 Middle East and Africa Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Acute Invasive Aspergillosis Treatment Market
9.4.5.1.1 South Africa Acute Invasive Aspergillosis Treatment Market by Drug Type
9.4.5.1.2 South Africa Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.4.5.2 Saudi Arabia Acute Invasive Aspergillosis Treatment Market
9.4.5.2.1 Saudi Arabia Acute Invasive Aspergillosis Treatment Market by Drug Type
9.4.5.2.2 Saudi Arabia Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.4.5.3 U.A.E Acute Invasive Aspergillosis Treatment Market
9.4.5.3.1 U.A.E Acute Invasive Aspergillosis Treatment Market by Drug Type
9.4.5.3.2 U.A.E Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.4.5.4 Rest of Middle East and Africa Acute Invasive Aspergillosis Treatment Market
9.4.5.4.1 Rest of Middle East and Africa Acute Invasive Aspergillosis Treatment Market by Drug Type
9.4.5.4.2 Rest of Middle East and Africa Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Acute Invasive Aspergillosis Treatment Market Overview
9.5.2 South and Central America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis
9.5.3 South and Central America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Acute Invasive Aspergillosis Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Acute Invasive Aspergillosis Treatment Market
9.5.5.1.1 Brazil Acute Invasive Aspergillosis Treatment Market by Drug Type
9.5.5.1.2 Brazil Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.5.5.2 Argentina Acute Invasive Aspergillosis Treatment Market
9.5.5.2.1 Argentina Acute Invasive Aspergillosis Treatment Market by Drug Type
9.5.5.2.2 Argentina Acute Invasive Aspergillosis Treatment Market by Distribution Channel
9.5.5.3 Rest of South and Central America Acute Invasive Aspergillosis Treatment Market
9.5.5.3.1 Rest of South and Central America Acute Invasive Aspergillosis Treatment Market by Drug Type
9.5.5.3.2 Rest of South and Central America Acute Invasive Aspergillosis Treatment Market by Distribution Channel
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET, KEY COMPANY PROFILES
12.1. GLAXOSMITHKLINE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MYLAN PHARMACEUTICALS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. NOVARTIS AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBOTT LABORATORIES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA PLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. JOHNSON AND JOHNSON
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TAKEDA PHARMACEUTICAL COMPANY LTD.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ASTELLAS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. GlaxoSmithKline
2. Mylan Pharmaceuticals, Inc.
3. Novartis AG
4. Abbott Laboratories
5. Eli Lilly and Company
6. AstraZeneca Plc
7. Pfizer, Inc.
8. Johnson & Johnson
9. Takeda Pharmaceutical Company Ltd.
10. Astellas
11. Basilea Pharmaceutica International Ltd
TIPRE00023423
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking